Search News

Corporate Industry Technology Medical Updates

Technological Innovation

Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Corporate
magAssist Forges University-Enterprise Cooperation with Domestic and International Universities to Empower Innovative Talents Cultivation Scheme 2023-01-12
Corporate
2021 BlackBOX Melbourne X magAssist: A Collision between Design and Innovation 2021-12-28
Corporate
magAssist was named a potential unicorn company in Jiangsu Province 2021-12-02
Corporate
magAssist Awarded the Jiangsu Zifeng Award for Technological Innovation 2025-12-18
Corporate
From China to the Global Stage: magAssist Selected Among Fortune’s 23 Featured Healthcare Companies 2025-11-15
Industry
Showcasing magAssist's Extracorporeal Support Solutions at 36th Annual ELSO Conference 2025-09-30
Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
magAssist Included in 2022 China Valuable Companies List 2023-01-31

Tabs： heart transfer, acute heart failure, MoyoAssist Extra-VAD, multi-organ failure, LVAD, life support technologies, 30 days life support, extracorporeal artificial hearts, Mechanical Circulatory Support, a fully magnetic levitation blood pump, future healthcare,